Evan Anderson Embarks on New Journey


Evan Anderson headshot

After more than 10 years at the Emory VTEU, Evan Anderson, MD, VTEU co-director and multiple principal investigator, will be embarking on an exciting new endeavor at Moderna leading infectious disease epidemiology.

“It has been a great pleasure to work with Evan. He is a meticulous scientist, a consummate team player, and a tireless champion for vaccines and child health. I will personally miss his wit and good humor. I look forward to collaborations with him in his new role,” says Kathy Neuzil, MD, IDCRC PI and Leadership Group co-chair.

Anderson played a pivotal role during the height of the COVID-19 pandemic, leading vaccine clinical trials for adults and children. He co-chaired the Moderna pediatric KidCOVE trial where the results directly contributed to an Emergency Use Authorization for the Moderna vaccine in children 6 months to <12 years of age. In addition, Anderson provided oversight for the Pfizer COVID vaccine trials that provided evidence to support COVID boost doses and variant-containing boost dosing. Read more about his IDCRC work

“His 10 years at the Emory VTEU have been truly remarkable. I want to thank Evan for his tireless efforts in making diseases preventable especially through vaccines against respiratory diseases and vaccines for children. It has been a privilege working with him this past decade,” says Nadine Rouphael, MD, Emory VTEU PI.

He made a tremendous impact as a professor of pediatrics and medicine at Emory University School of Medicine, as an attending physician in adult and pediatric infectious diseases at Emory Healthcare and Children’s Healthcare of Atlanta, and as a clinical vaccinologist. We wish him the very best and thank him for all the wonderful work he has contributed to the pediatric and adult infectious disease communities. 

“Evan, we will miss you! Congratulations and thank you for over 10 years of impact for Emory, the VTEUs, and especially for advancing vaccines for children and adults. We (and I mean the global we) are so much better for your contributions. Thank you, my friend, for all your help and support of the IDCRC. I also want to thank your family who have supported you during the challenges of COVID-19 and beyond,” says David Stephens, MD, IDCRC contact PI and Leadership Group chair.